| Identification | Back Directory | [Name]
1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil | [CAS]
2095417-68-6 | [Synonyms]
1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil
1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil
2,?4(1H,?3H)?-?Pyrimidinedione, 1-?(5,?6-?dideoxy-?2-?O-?methyl-?6-?phosphono-?β-?D-?ribo-?hexofuranosyl)?- | [Molecular Formula]
C11H17N2O8P | [MOL File]
2095417-68-6.mol | [Molecular Weight]
336.24 |
| Hazard Information | Back Directory | [Uses]
1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|